Therapeutic approach to target mesothelioma cancer cells using the Wnt antagonist, secreted frizzled-related protein 4: Metabolic state of cancer cells
- 1 February 2016
- journal article
- Published by Elsevier in Experimental Cell Research
- Vol. 341 (2) , 218-224
Abstract
No abstract availableKeywords
Funding Information
- Rotary Club of Belmont, W.A
- Australian Rotary Health Research Fund
- Curtin University
- School of Biomedical Sciences (Curtin University)
- Commercialisation Advisory Board of Curtin University
- Cancer Council, WA
- Actinogen Ltd, Perth
This publication has 31 references indexed in Scilit:
- Expression profile and function of Wnt signaling mechanisms in malignant mesothelioma cellsBiochemical and Biophysical Research Communications, 2013
- Secreted frizzled-related protein 4 expression is positively associated with responsiveness to Cisplatin of ovarian cancer cell lines in vitro and with lower tumour grade in mucinous ovarian cancersBMC Cell Biology, 2012
- The Role of the Cysteine-Rich Domain and Netrin-Like Domain of Secreted Frizzled-Related Protein 4 in Angiogenesis Inhibition In VitroOncology Research, 2012
- Advances in the biology of malignant pleural mesotheliomaCancer Treatment Reviews, 2011
- Secreted Frizzled-Related Protein 4The American Journal of Pathology, 2010
- Understanding the Warburg Effect: The Metabolic Requirements of Cell ProliferationScience, 2009
- SFRP-4 abrogates Wnt-3a-induced β-catenin and Akt/PKB signalling and reverses a Wnt-3a-imposed inhibition of in vitro mammary differentiationJournal of Molecular Signaling, 2008
- WNT signaling in malignant mesotheliomaFrontiers in Bioscience-Landmark, 2006
- Dickkopf-1 antagonizes Wnt signaling independent of β-catenin in human mesotheliomaBiochemical and Biophysical Research Communications, 2004
- Expression of the secreted frizzled-related protein gene family is downregulated in human mesotheliomaOncogene, 2004